Simplex Trading’s GT Biopharma GTBP Stock Holding History

Simplex Trading’s Portfolio GTBP Stock Details GTBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23	Closed	-$2K	–	10283
2022 Q2	$2K	Buy	23 +6	+35%	+$455	﹤0.01%	9352
2022 Q1	$1K	Sell	17 -80	-82%	-$7.06K	﹤0.01%	10075
2021 Q4	$8K	Buy	+97	New	+$14.5K	﹤0.01%	9195

Other funds holding GTBP

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Simplex Trading's GTBP Position: Q1 2024 in Review

Simplex Trading sold out of GT Biopharma (GTBP) in Q1 2024, closing a stake of 10 shares.

Simplex Trading first reported a position in GTBP in Q2 2021 and held it in 10 quarters. The position peaked at $19K in Q4 2021. 17 funds tracked by Wall St. Rank hold GTBP as of Q1 2024.

Simplex Trading reported no remaining GT Biopharma position as of Q1 2024 after selling out during the quarter.
Simplex Trading sold 10 GT Biopharma shares in Q1 2024.
Simplex Trading first reported a position in GT Biopharma in Q2 2021 and held it in 10 quarters.
Simplex Trading's GT Biopharma position peaked at $19K in Q4 2021.
17 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2024.

Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.